Bleomycin Injection

We are offering bleomycin injection-blm-02 (15 / 30 mg)
which is an antineoplastic agent which belongs to the group of cytotoxic glycopeptide antibiotics. It also acts as a sclerosing agent during the treatment of malignant pleural effusion. Bleomycin injection is used in the management of variety of neoplasms such as squamous cell carcinoma, lymphomas, testicular carcinoma and malignant pleural effusion. Bleomycin injection stops the growth of cancer cells by the inhibition of dna, rna and protein synthesis. Patients those who are hypersensitive to the components of the formulation, pregnant women and nursing mothers are not supposed to take this medication. Bleomycin injection should be administered with caution in patients with impaired renal function or pulmonary function. No drug interactions has been reported with bleomycin injection.
Recommended dose:0.25 to 0.50 units/kg (10 to 20 units/m²) of bleomycin injection is given intravenously, intramuscularly, or subcutaneously weekly or twice weekly.